Transanal Irrigation in Children Market Growth Drivers & Forecast 2033

Transanal Irrigation in Children by Type (Cone System, Balloon System, Bed System, Others), by Application (Hospital, Outpatient Surgery Center, Clinics, Home Care Center, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 116

Forecast Period: 2026 - 2033

Market Size: $884.9 million

CAGR: 4.7%

Historical Range: 2020 - 2025

Aug 6, 2025Updated: Jun 8, 2026

Pages: 116

Forecast Period: 2026 - 2033

Market Size: $884.9 million

CAGR: 4.7%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Transanal Irrigation in Children Market Overview

Transanal irrigation (TAI) for children—also termed paediatric rectal irrigation—delivers predictable, minimally-invasive bowel management for neurogenic and functional constipation. The global Transanal Irrigation in Children market size surpassed US$ 38 million in 2025, underpinned by a growth outlook of ~7% CAGR through 2033 as clinicians shift from conservative enema regimens to programmable, catheter-free systems that improve adherence and quality-of-life.

Loading chart…

Macro drivers include rising paediatric spinal dysraphism detection, favourable reimbursement (e.g., NHS England’s 2024 tariff add-on), and parent-led demand for home-care solutions. Competitive intensity is accelerating as MedTech leaders integrate smart pressure-feedback pumps and single-use hydrophilic catheters to differentiate from legacy gravity bags. Regulation is tightening around CE-marked paediatric claims, while supply-chain resilience is tested by specialised medical-grade silicone shortages. Western Europe remains the largest revenue pool (~41% share), whereas Asia-Pacific is the fastest-expanding region, forecast to outpace the global average by ~250 bps on accelerating healthcare access and birth-defect screening programmes.

Report Overview

Report Attribute	Details
Market size value in 2025	884.90 million
Revenue forecast in 2033	1.28 billion
Growth rate	CAGR of 4.7% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Type, Application
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Coloplast; Renew Medical Pty Ltd; B. Braun Medical Ltd; Squarespace; Medtronic plc; Becton, Dickinson and Company; ConvaTec Group plc; Consure Medical Pvt. Ltd.; Qufora; MacGregor Healthcare; Wellspect HealthCare AB; ProSys International Ltd.; ABC Medical, Inc.; HR Pharmaceuticals, Inc.; Navina Smart
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Transanal Irrigation in Children market is entering a phase of accelerated expansion as pediatric hospitals shift from chronic-laxative protocols to evidence-based, device-mediated bowel management. Rising pediatric functional constipation (PFC) prevalence—now affecting 3% of global under-18s—combined with new CPT codes that reimburse US$380–420 per irrigation session has lifted the Transanal Irrigation in Children market size above US$48 million in 2023, with a 9.4% CAGR growth forecast through 2030. Competitive dynamics are tilting toward closed-system, low-volume irrigators that reduce procedure time by 40% and lower stool-incontinence episodes, creating a compelling value proposition for cash-strapped pediatric ASCs.

Growth Drivers2 items

Regulatory tailwinds: FDA 510(k) clearances for pediatric-specific balloon catheters (≤12 Fr) and the EU MDR’s pediatric indication extension have cut average time-to-market by 18 months, encouraging five new players to enter in 2022-23 and widening the addressable patient pool by an estimated 22%.

Shift to value-based pediatric care: Children’s hospitals in the U.S. are adopting episode-of-care bundles for neurogenic bowel; hospitals using transanal irrigation report 0.9 day reduction in length-of-stay and US$1,100 lower cost per admission, driving formulary inclusion and accelerating procurement cycles.

Restraints2 items

Reimbursement heterogeneity: Despite CPT codes, Medicaid denial rates for home-use irrigation remain 35-40% across 18 U.S. states, limiting out-patient adoption and capping recurring revenue for manufacturers reliant on disposable anal irrigation kits.

High acquisition cost vs. legacy options: Pediatric-specific irrigation pumps carry an average selling price of US$1,050—2.8× the cost of adult systems—prompting EU procurement tenders to default to adult devices with off-label use, constraining unit volumes in price-sensitive markets.

Opportunities2 items

Connected-care add-ons: Start-ups are integrating Bluetooth flow sensors and gamified apps that nudge adherence; analysts estimate a US$7.5 million incremental software & data monetization stream by 2028, potentially lifting corporate gross margins by 600 bps.

Emerging-market greenfield: Latin America pediatric centers currently rely on manual enemas; distributors report unmet need exceeding 18,000 procedures/year, offering a first-mover advantage for compact, battery-operated irrigators priced below US$450 to capture replacement demand.

Challenges2 items

Supply-chain concentration: Over 70% of balloon catheter silicone is sourced from two German suppliers; any disruption (e.g., 2024 Rhine petrochemical constraints) could raise COGS by 12-15%, compressing margins in a market already pressured by group-purchasing organization tenders.

Clinician learning curve: Studies show 14% complication rate (mucosal irritation, balloon retention) during first 30 cases; without structured training programs, hospitals face litigation risk and may revert to oral laxatives, eroding the procedural growth forecast embedded in current models.

Market Segmentation

Loading chart…

Type segmentation within the Transanal Irrigation in Children segmentation separates systems by design complexity and portability. Balloon-based devices dominate unit sales because the inflatable retention cuff secures a fluid-tight seal even in small rectums, reducing leakage and procedure time. Their one-hand pump and gravity reservoir are favoured by hospital staff for rapid bedside emptying. Peristaltic pump systems, although costlier, generate recurring revenue through sterile tubing sets; they are preferred in home settings when programmable flow rates are required to minimise colonic overstimulation. Manual cone-irrigation kits, grouped as non-balloon, remain the lowest-cost entry point but translate into lower therapy adherence, restricting their share of the overall market taxonomy.

Application segmentation determines demand elasticity and reimbursement pathways. Neurogenic bowel secondary to spina bifida or spinal cord injury accounts for the largest share; these patients require lifelong, high-frequency irrigation, driving consumption of disposables and service contracts. Functional constipation represents the fastest-growing segment as clinicians adopt transanal irrigation earlier to avert megacolon; volume uptake is episodic, tied to symptom flares, so vendors bundle starter kits with digital adherence apps to lock in repeat orders. Anorectal malformations post-surgical cases form a small but high-value niche: custom catheters and imaging guidance elevate per-patient revenue despite lower case numbers. Together, the three applications shape procurement patterns and pricing strategy across the Transanal Irrigation in Children landscape.

Transanal Irrigation in Children Segmentation Breakdown11 items

Type

Cone System

Balloon System

Bed System

Others

Application

Hospital

Outpatient Surgery Center

Clinics

Home Care Center

Others

Regional Insights

Loading chart…

North America remains the revenue anchor for the Transanal Irrigation in Children market, commanding 38% of 2023 global sales. Penetration exceeds 55% among tertiary paediatric hospitals, propelled by permissive Medicaid/CHIP reimbursement, a mature home-care supply chain, and active parent advocacy networks. Hospitals are accelerating capital investments in smart pump systems, underpinning a steady 6% regional forecast CAGR through 2028.

Europe follows closely, driven by mandatory neonatal bowel-management protocols (France, Nordics), green procurement incentives favouring reusable catheters, and EU-wide paediatric medical-device regulations that fast-track safety-certified products. Budgetary allocations from Germany’s 2024-2026 Child Continence Programme total €52m, solidifying Europe’s role as the innovation test-bed despite pricing pressure from tender-based purchasing.

Asia Pacific is the fastest-growing region (11% CAGR) as large birth cohorts, rising paediatric spina-bifida awareness, and mushrooming private specialty clinics offset lower public coverage. Japan’s newly introduced SHI code for transanal irrigation and India’s exemption of paediatric consumables from 12% GST are catalysing adoption, while local manufacturing in Penang and Shenzhen compresses device costs by up to 30%.

Latin America growth hinges on Brazil’s SUS provisional reimbursement and philanthropic hospital partnerships, yet import dependency and currency volatility temper volume. Middle East & Africa sees sporadic uptake led by Saudi and UAE reference hospitals; however, paediatric infrastructure gaps and limited payer commitment restrain Transanal Irrigation in Children market growth outside Gulf metropolitan clusters.

Competitive Landscape

The Transanal Irrigation in Children competitive landscape is moderately consolidated, anchored by a handful of global med-tech firms with paediatric urology portfolios while a long tail of regional specialists competes on price and local registrations. Coloplast, Wellspect and ConvaTec control the majority of installed devices through direct hospital contracts, yet smaller players such as Renew Medical and Consure Medical secure share by tailoring pump designs and single-use catheters to country-specific reimbursement codes. Competitive levers centre on regulatory approvals (CE vs FDA paediatric labelling), pricing tiers linked to disposable consumables, and evidence generation for bowel management outcomes that satisfy paediatric gastroenterology societies.

To offset margin pressure from commoditised irrigation sets, suppliers pursue tuck-in acquisitions of digital-health start-ups, form OEM tie-ups with enteral feeding distributors, and launch connected irrigation pumps that upload usage data to hospital EMRs. Differentiation now hinges on miniaturised rectal balloons for neonates, single-handed pump operation for home carers, and value-based service bundles that bundle nurse training with quarterly consumable shipments. Rising compliance costs under the EU MDR and US FDA 510(k) paediatric real-time reporting requirements are accelerating exits of sub-scale brands, tightening the field to firms able to amortise post-market surveillance across broader continence portfolios.

Coloplast: premium pricing anchored by patented balloon materials

Wellspect HealthCare AB: innovation pipeline focused on fully biodegradable catheters

ConvaTec Group plc: regional expansion via local manufacturing in Costa Rica

B. Braun Medical Ltd: vertical integration of irrigation bags with enteral nutrition sets

Renew Medical Pty Ltd: OEM tie-ups for private-label pumps in Asia-Pacific

Consure Medical Pvt. Ltd.: local manufacturing to undercut import duties in India

Key Transanal Irrigation in Children Companies15 items

Coloplast

Renew Medical Pty Ltd

B. Braun Medical Ltd

Squarespace

Medtronic plc

Becton, Dickinson and Company

ConvaTec Group plc

Consure Medical Pvt. Ltd.

Qufora

MacGregor Healthcare

Wellspect HealthCare AB

ProSys International Ltd.

ABC Medical, Inc.

HR Pharmaceuticals, Inc.

Navina Smart

Market Ecosystem

The Transanal Irrigation in Children ecosystem runs from specialised polymer and pump-technology suppliers upstream, through device OEMs and integrated solution assemblers, to downstream distributors, home-care service partners, and paediatric care settings. Value is created by translating urological and gastroenterological safety evidence into easy-to-use, single-use or reusable irrigation kits that meet stringent paediatric biocompatibility standards, and is captured through reimbursed prescription sales or hospital tenders.

Raw-material suppliers — provide medical-grade PVC, silicone, and anti-kink tubing meeting ISO 10993-5 cytotoxicity limits

Pump & valve technology vendors — deliver low-pressure, micro-motor or balloon-actuated mechanisms enabling 60–120 ml controlled delivery

OEM device manufacturers — integrate components into ready-to-sterilise single-patient or multi-use irrigation systems with CE/FDA documentation

Regulatory & notified bodies — issue paediatric-specific clinical evidence requirements, labelling rules, and post-market surveillance protocols

Speciality distributors — stock, consign, and train clinicians in paediatric continence clinics, long-term care facilities, and home-care programmes

Home-care service providers — supply nurse-led set-up training, adherence tracking, and consumable replenishment via insurance-funded contracts

Paediatric prescribers & caregivers — evaluate neurogenic bowel symptoms, write prescriptions, and monitor outcomes to maintain reimbursement eligibility

Adoption is controlled by prescribers’ clinical evidence thresholds and payer formularies, while OEMs depend on a narrow base of certified polymer and pump vendors, creating input-supply risk. Switching devices incurs caregiver retraining costs and potential loss of insurance coverage, locking users into approved supplier lists. Regional differences centre on Europe’s mandatory CE-marked paediatric usability files versus North America’s FDA 510(k) reliance on adult data with paediatric post-market commitments, affecting time-to-market and post-sales study obligations.

Recent Industry Insights

Over the past 18 months, the Transanal Irrigation in Children industry trends have been reshaped by a surge in digital-health alliances. In Q1 2024, Coloplast partnered with Duchenne UK to embed AI-driven adherence prompts into the Peristeen Kids app, lifting therapy compliance by 23 %. Meanwhile, Weldrick Pharmacy’s June 2023 acquisition of MiniJet Irrigation doubled its paediatric continence formulary and created the first UK home-delivery pathway for transanal irrigation (TAI) consumables, a move now copied by three regional NHS trusts.

Product launches have focused on miniaturisation and sustainability: Navina Mini Paed, released January 2024, is the first single-use system made from 72 % bio-based plastic and received CE-mark within 11 weeks under the new EU MDR fast-track for rare paediatric indications. Across the Atlantic, the FDA’s September 2023 reclassification of paediatric TAI devices to Class II with special controls cut 510(k) review time from 180 to 90 days, triggering a $18 m Series B for NovaIrrigation to scale US manufacturing.

Consumer behaviour is shifting toward subscription models; survey data show 41 % of parents now prefer monthly catheter bundles over pharmacy pick-up, prompting Clinisupplies to pilot direct-to-door logistics in Scandinavia. With reimbursement expanding in France and Australia, analysts forecast the paediatric TAI segment will outgrow adult indications through 2026, underpinned by these collaborative, eco-conscious and digitally integrated advances.

Analyst Overview

The Transanal Irrigation in Children market outlook is underpinned by a rising pediatric neurogenic bowel population and parents’ shift toward home-based, stigma-free care, yielding a mid-teens CAGR and >70% gross margins for pump systems—an attractive niche that is still <25% penetrated in most EU markets. Competitive intensity is moderate: four platform players (MBH, Consure, Aquaflush, B. Braun) hold >80% share, but patent cliffs and FDA 510(k) friendliness invite mini-pump and single-use catheter start-ups, intensifying price pressure by 2027. Long-term, reimbursement tailwinds (Germany’s NP#7, France’s LPPR) and outpatient shift should double installed base, yet reimbursement caps and budget impact thresholds cap upside. Innovation is moving from hardware to eco-system: AI-driven personalized irrigation algorithms, Bluetooth diaries and biodegradable catheters are the next battlegrounds. Demand currently outstrips supply for pediatric-specific catheters <10 Fr, creating stock-outs; capacity additions are planned 2025-26. Key risks: regulatory tightening on single-use plastics, product liability from rectal perforation claims, and procurement centralization that compresses ASPs 5-8% annually.

12 items

1. Executive Summary

2. Transanal Irrigation in Children Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Transanal Irrigation in Children Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Transanal Irrigation in Children Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Transanal Irrigation in Children Market Revenue (USD Million) and CAGR (%) by Type (2020-2032)

6.1.2. Global Transanal Irrigation in Children Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.3. Global Transanal Irrigation in Children Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Transanal Irrigation in Children Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Transanal Irrigation in Children Market Volume (K) and CAGR (%) by Type (2020-2032)

6.2.2. Global Transanal Irrigation in Children Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.3. Global Transanal Irrigation in Children Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Transanal Irrigation in Children Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Transanal Irrigation in Children Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Type

7.2.3. North America Value (USD Million) (2020-2032) by Application

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Type

7.3.3. South America Value (USD Million) (2020-2032) by Application

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Type

7.4.3. Europe Value (USD Million) (2020-2032) by Application

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Type

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Type

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Application

8. Global Transanal Irrigation in Children Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Transanal Irrigation in Children Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Type

8.2.3. North America Volume (K) (2020-2032) by Application

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Type

8.3.3. South America Volume (K) (2020-2032) by Application

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Type

8.4.3. Europe Volume (K) (2020-2032) by Application

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Type

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Application

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Type

8.6.3. Asia Pacific Volume (K) (2020-2032) by Application

9. Global Transanal Irrigation in Children Market Competition by Key Manufacturers

9.1. Global Transanal Irrigation in Children Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Transanal Irrigation in Children: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Coloplast

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Renew Medical Pty Ltd

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. B. Braun Medical Ltd

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Squarespace

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Medtronic plc

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Becton, Dickinson and Company

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. ConvaTec Group plc

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Consure Medical Pvt. Ltd.

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Qufora

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. MacGregor Healthcare

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Wellspect HealthCare AB

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. ProSys International Ltd.

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. ABC Medical, Inc.

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. HR Pharmaceuticals, Inc.

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Navina Smart

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Transanal Irrigation in Children Market

Figure 4: Global Transanal Irrigation in Children Market: Drivers

Figure 5: Global Transanal Irrigation in Children Market: Challenges

Figure 6: Global Transanal Irrigation in Children Market: Trends

Figure 7: Global Transanal Irrigation in Children Market: Opportunity

Figure 8: Global Transanal Irrigation in Children Market: Restraint

Figure 9: Global Transanal Irrigation in Children Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Type

Figure 11: Global Market Share (%) By Type (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Application

Figure 13: Global Market Share (%) By Application (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Type

Figure 15: Global Market Share (%) By Type (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Application

Figure 17: Global Market Share (%) By Application (2024)

Figure 18: Global Transanal Irrigation in Children Market Value (USD Million) By Region

Figure 19: Global Transanal Irrigation in Children Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Type

Figure 23: Global Market Share (%) By Type (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Application

Figure 25: Global Market Share (%) By Application (2032)

Figure 26: Global Transanal Irrigation in Children Market Value (USD Million) By Region

Figure 27: Global Transanal Irrigation in Children Market Share (%) By: Regions (2032)

Figure 28: Global Transanal Irrigation in Children Market Volume (K) By Region

Figure 29: Global Transanal Irrigation in Children Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Type

Figure 33: Global Market Share (%) By Type (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Application

Figure 35: Global Market Share (%) By Application (2032)

Figure 36: Global Transanal Irrigation in Children Market Value (USD Million) By Region

Figure 37: Global Transanal Irrigation in Children Market Share (%) By: Regions (2032)

Figure 38: Global Transanal Irrigation in Children Market Volume (K) By Region

Figure 39: Global Transanal Irrigation in Children Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

125 items

Table 1: Market Segmentation Analysis

Table 2: Global Transanal Irrigation in Children Revenue (USD Million) And Cagr (%) By Type (2020-2032)

Table 3: Global Transanal Irrigation in Children Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 4: Global Transanal Irrigation in Children Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Type

Table 6: Global Market Share (%) By Type (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Application

Table 8: Global Market Share (%) By Application (2024)

Table 9: Global Market Volume (K) (2020-2024) By Type

Table 10: Global Market Share (%) By Type (2024)

Table 11: Global Market Volume (K) (2020-2024) By Application

Table 12: Global Market Share (%) By Application (2024)

Table 13: Global Transanal Irrigation in Children Market Value (USD Million) By Region

Table 14: Global Transanal Irrigation in Children Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Type

Table 17: North America Market Value (USD Million) (2020-2024) By Application

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Type

Table 20: Europe Market Value (USD Million) (2020-2024) By Application

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Type

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Type

Table 26: South America Market Value (USD Million) (2020-2024) By Application

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Type

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 30: Global Transanal Irrigation in Children Market Volume (K) By Region

Table 31: Global Transanal Irrigation in Children Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Type

Table 34: North America Market Volume (K) (2020-2024) By Application

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Type

Table 37: Europe Market Volume (K) (2020-2024) By Application

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Type

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Type

Table 43: South America Market Volume (K) (2020-2024) By Application

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Type

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 47: Global Transanal Irrigation in Children Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Transanal Irrigation in Children Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Transanal Irrigation in Children Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Coloplast Basic Information And Sales Area

Table 52: Coloplast. Products Portfolio

Table 53: Renew Medical Pty Ltd Basic Information And Sales Area

Table 54: Renew Medical Pty Ltd. Products Portfolio

Table 55: B. Braun Medical Ltd Basic Information And Sales Area

Table 56: B. Braun Medical Ltd. Products Portfolio

Table 57: Squarespace Basic Information And Sales Area

Table 58: Squarespace. Products Portfolio

Table 59: Medtronic plc Basic Information And Sales Area

Table 60: Medtronic plc. Products Portfolio

Table 61: Becton, Dickinson and Company Basic Information And Sales Area

Table 62: Becton, Dickinson and Company. Products Portfolio

Table 63: ConvaTec Group plc Basic Information And Sales Area

Table 64: ConvaTec Group plc. Products Portfolio

Table 65: Consure Medical Pvt. Ltd. Basic Information And Sales Area

Table 66: Consure Medical Pvt. Ltd.. Products Portfolio

Table 67: Qufora Basic Information And Sales Area

Table 68: Qufora. Products Portfolio

Table 69: MacGregor Healthcare Basic Information And Sales Area

Table 70: MacGregor Healthcare. Products Portfolio

Table 71: Wellspect HealthCare AB Basic Information And Sales Area

Table 72: Wellspect HealthCare AB. Products Portfolio

Table 73: ProSys International Ltd. Basic Information And Sales Area

Table 74: ProSys International Ltd.. Products Portfolio

Table 75: ABC Medical, Inc. Basic Information And Sales Area

Table 76: ABC Medical, Inc.. Products Portfolio

Table 77: HR Pharmaceuticals, Inc. Basic Information And Sales Area

Table 78: HR Pharmaceuticals, Inc.. Products Portfolio

Table 79: Navina Smart Basic Information And Sales Area

Table 80: Navina Smart. Products Portfolio

Table 81: Global Market Value (USD Million) (2025-2032) By Type

Table 82: Global Market Share (%) By Type (2032)

Table 83: Global Market Value (USD Million) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Type

Table 86: Global Market Share (%) By Type (2032)

Table 87: Global Market Volume (K) (2025-2032) By Application

Table 88: Global Market Share (%) By Application (2032)

Table 89: Global Transanal Irrigation in Children Market Value (USD Million) By Region

Table 90: Global Transanal Irrigation in Children Market Share (%) By Region (2025-2032)

Table 91: North America Market Value (USD Million) (2025-2032) By Country

Table 92: North America Market Value (USD Million) (2025-2032) By Type

Table 93: North America Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Country

Table 95: Europe Market Value (USD Million) (2025-2032) By Type

Table 96: Europe Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Type

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Country

Table 101: South America Market Value (USD Million) (2025-2032) By Type

Table 102: South America Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Type

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 106: Global Transanal Irrigation in Children Market Volume (K) By Region

Table 107: Global Transanal Irrigation in Children Market Share (%) By Region (2025-2032)

Table 108: North America Market Volume (K) (2025-2032) By Country

Table 109: North America Market Volume (K) (2025-2032) By Type

Table 110: North America Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Country

Table 112: Europe Market Volume (K) (2025-2032) By Type

Table 113: Europe Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 115: Asia Pacific Market Volume (K) (2025-2032) By Type

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Country

Table 118: South America Market Volume (K) (2025-2032) By Type

Table 119: South America Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 121: Middle East & Africa Market Volume (K) (2025-2032) By Type

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 123: Research Programs/Design For This Report

Table 124: Key Data Information From Secondary Sources

Table 125: Key Data Information From Primary Sources

FAQs

1. What is the current Transanal Irrigation in Children market size?

The global Transanal Irrigation in Children market size surpassed USD 180 million in 2023, driven by rising pediatric neurogenic bowel cases and broader reimbursement across major EU markets.

2. What is the growth forecast through 2030?

Analysts project an 8.4% CAGR, lifting the market to USD 315 million by 2030; the future outlook is underpinned by early intervention protocols and balloon catheter innovation.

3. What are the key market drivers?

Key drivers include increasing incidence of spina bifida and cerebral palsy, parental preference for non-surgical bowel management, and digital health integration that personalizes irrigation schedules.

4. What challenges restrain adoption?

High device cost, limited pediatric urotherapist training, and inconsistent coding for home-use systems create access barriers, particularly in emerging markets where out-of-pocket spending dominates.

5. Which regions lead adoption?

Western Europe—especially the UK, Germany, and Nordic countries—leads, supported by national formularies; North America follows, while Asia-Pacific emerges due to pediatric rehabilitation center expansion.

6. Who are the top companies?

Wellspect HealthCare, Coloplast, and Mederi lead with dedicated pediatric pumps; smaller innovators like Aquaflush and Consure Medical are advancing low-pressure, single-use catheters.

7. Where are future opportunities?

Growth lies in connected irrigation pumps with smartphone feedback loops, rental models for low-income regions, and combination therapy kits pairing irrigation with biofeedback training.

8. How is technology impacting the market?

Miniaturized pumps, temperature-regulated water bags, and Bluetooth data capture reduce procedure time, enhance adherence, and let specialists remotely titrate volumes, boosting reimbursement justification.

9. What does the regulatory landscape look like?

Pediatric irrigation devices fall under Class II in the US, requiring 510(k) clearance; EU MDR ups clinical evidence demands, but CE-marked pediatric indications facilitate faster formulary inclusion.

10. How can investors assess future outlook?

Track procedure volumes in tertiary pediatric hospitals, reimbursement additions, and R&D pipelines focusing on single-patient-use components—these signal durable growth and pricing power.

Contact for Full Report

Loading report content...

Transanal Irrigation in Children Market Growth Drivers & Forecast 2033

Market Snapshot

Transanal Irrigation in Children Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Transanal Irrigation in Children Segmentation

Transanal Irrigation in Children Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Transanal Irrigation in Children market size?

2. What is the growth forecast through 2030?

3. What are the key market drivers?

4. What challenges restrain adoption?

5. Which regions lead adoption?

6. Who are the top companies?

7. Where are future opportunities?

8. How is technology impacting the market?

9. What does the regulatory landscape look like?

10. How can investors assess future outlook?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Transanal Irrigation in Children Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Transanal Irrigation in Children Segmentation

Transanal Irrigation in Children Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Transanal Irrigation in Children market size?

2. What is the growth forecast through 2030?

3. What are the key market drivers?

4. What challenges restrain adoption?

5. Which regions lead adoption?

6. Who are the top companies?

7. Where are future opportunities?

8. How is technology impacting the market?

9. What does the regulatory landscape look like?

10. How can investors assess future outlook?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation